Press releases 2014

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2014-12-18 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Utfall i Skiljedom angående XVIVO Perfusions rättigheter till Vivoline-patent
2014-12-18 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Decision of the Arbitration Board regarding XVIVO Perfusion’s rights to the Vivoline patents
2014-11-20 16:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO obtains financing from Vinnova for cancer research
2014-11-20 16:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO får Vinnova–finansiering för cancerforskning
2014-10-24 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q3
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT FDA GODKÄNNANDE FÖR XPS™ OCH STEEN SOLUTION™
2014-10-24 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q3
CONTINUED STRONG SALES GROWTH AND FDA APPROVAL FOR XPS™ AND STEEN SOLUTION™
2014-10-17 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-10-17 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-10-16 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2014-10-16 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2014-09-30 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation av den första XPS™:en i Asien
2014-09-30 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation of the first XPS™ in Asia
2014-09-19 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO får Horizon 2020 finansiering
2014-09-19 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO receives Horizon 2020 funding
2014-08-13 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO har erhållit marknadsgodkännande för STEEN Solution™ och XPS™ av FDA
2014-08-13 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO has received market approval from the FDA for STEEN Solution™ and XPS™.
2014-08-13 08:29
News
IR
English
Regulatory
VPML
Report
Interim
Q2
CONTINUED STRONG SALES GROWTH AND SEK 73 MILLION PRIVATE PLACEMENT
2014-08-13 08:29
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT RIKTAD NYEMISSION OM 73 MSEK
2014-08-07 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-08-07 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-07-07 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2014-07-07 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2014-06-26 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO has completed a private placement of shares
2014-06-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
Xvivo genomför en riktad nyemission
2014-06-25 17:31
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO Perfusion AB avser att genomföra en riktad emission av aktier
2014-06-25 17:31
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO intends to undertake a private placement of shares
2014-04-30 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I XVIVO PERFUSION AB (PUBL)
2014-04-30 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
REPORT FROM ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
2014-04-23 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q1
Delårsrapport januari – mars 2014
2014-04-23 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q1
Interim Report January - March 2014
2014-04-14 15:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call interim report
2014-04-14 15:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2014-04-07 09:30
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2013
2014-04-07 09:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual report 2013
2014-03-31 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XPS™ systemet har erhållit CE-märke
2014-03-31 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XPS™ has received CE mark
2014-03-28 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)
2014-03-28 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
KALLELSE TILL ÅRSSTÄMMA I XVIVO PERFUSION AB (PUBL)
2014-03-21 08:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
FDA:s Expertpanelen röstade enhälligt för att XPS™ med STEEN Solution™ uppfyller kraven för HDE
2014-03-21 08:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
The FDA Advisory Panel voted unanimously that XPS™ with STEEN Solution™ meets the requirements for HDE
2014-03-14 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Progress made in the NOVEL study in the USA
2014-03-14 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Framsteg i NOVEL studien i USA
2014-02-07 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
Report on Operations 2013
2014-02-07 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
Bokslutskommuniké 2013
2014-01-29 14:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO expands the US study with another leading transplant center
2014-01-29 14:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO utökar USA-studien med ytterligare en ledande transplantationsklinik
2014-01-28 14:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké 2013
2014-01-28 14:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations 2013
2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2014-12-18 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Utfall i Skiljedom angående XVIVO Perfusions rättigheter till Vivoline-patent
2014-12-18 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Decision of the Arbitration Board regarding XVIVO Perfusion’s rights to the Vivoline patents
2014-11-20 16:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO obtains financing from Vinnova for cancer research
2014-11-20 16:00
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
XVIVO får Vinnova–finansiering för cancerforskning
2014-10-24 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q3
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT FDA GODKÄNNANDE FÖR XPS™ OCH STEEN SOLUTION™
2014-10-24 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q3
CONTINUED STRONG SALES GROWTH AND FDA APPROVAL FOR XPS™ AND STEEN SOLUTION™
2014-10-16 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2014-10-16 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2014-09-30 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation av den första XPS™:en i Asien
2014-09-30 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Installation of the first XPS™ in Asia
2014-09-19 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO får Horizon 2020 finansiering
2014-09-19 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO receives Horizon 2020 funding
2014-08-13 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO har erhållit marknadsgodkännande för STEEN Solution™ och XPS™ av FDA
2014-08-13 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO has received market approval from the FDA for STEEN Solution™ and XPS™.
2014-08-13 08:29
News
IR
English
Regulatory
VPML
Report
Interim
Q2
CONTINUED STRONG SALES GROWTH AND SEK 73 MILLION PRIVATE PLACEMENT
2014-08-13 08:29
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
FORTSATT STARK FÖRSÄLJNINGSTILLVÄXT SAMT RIKTAD NYEMISSION OM 73 MSEK
2014-07-07 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2014-07-07 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2014-06-26 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
XVIVO has completed a private placement of shares
2014-06-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Action
Shares
Issuance
Xvivo genomför en riktad nyemission
Next